Akin-Akintayo OO - Search Results

1

Prevalence and Severity of Off-Centering During Diagnostic CT: Observations From 57,621 CT scans of the Chest, Abdomen, and/or Pelvis.

Akin-Akintayo OO, Alexander LF, Neill R, Krupinksi EA, Tang X, Mittal PK, Small WC, Moreno CC. Akin-Akintayo OO, et al. Curr Probl Diagn Radiol. 2019 May-Jun;48(3):229-234. doi: 10.1067/j.cpradiol.2018.02.007. Epub 2018 Feb 23. Curr Probl Diagn Radiol. 2019. PMID: 29576415

2

Prospective evaluation of fluciclovine (¹⁸F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients.

Akin-Akintayo O, Tade F, Mittal P, Moreno C, Nieh PT, Rossi P, Patil D, Halkar R, Fei B, Master V, Jani AB, Kitajima H, Osunkoya AO, Ormenisan-Gherasim C, Goodman MM, Schuster DM. Akin-Akintayo O, et al. Eur J Radiol. 2018 May;102:1-8. doi: 10.1016/j.ejrad.2018.02.006. Epub 2018 Feb 24. Eur J Radiol. 2018. PMID: 29685521 Free PMC article.

3

Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer.

Akin-Akintayo OO, Jani AB, Odewole O, Tade FI, Nieh PT, Master VA, Bellamy LM, Halkar RK, Zhang C, Chen Z, Goodman MM, Schuster DM. Akin-Akintayo OO, et al. Clin Nucl Med. 2017 Jan;42(1):e22-e28. doi: 10.1097/RLU.0000000000001379. Clin Nucl Med. 2017. PMID: 27749412 Free PMC article. Clinical Trial.

4

Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.

Odewole OA, Tade FI, Nieh PT, Savir-Baruch B, Jani AB, Master VA, Rossi PJ, Halkar RK, Osunkoya AO, Akin-Akintayo O, Zhang C, Chen Z, Goodman MM, Schuster DM. Odewole OA, et al. Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1773-83. doi: 10.1007/s00259-016-3383-8. Epub 2016 Apr 18. Eur J Nucl Med Mol Imaging. 2016. PMID: 27091135 Free PMC article.

5

MRI-based prostate and dominant lesion segmentation using cascaded scoring convolutional neural network.

Eidex ZA, Wang T, Lei Y, Axente M, Akin-Akintayo OO, Ojo OAA, Akintayo AA, Roper J, Bradley JD, Liu T, Schuster DM, Yang X. Eidex ZA, et al. Among authors: akin akintayo oo. Med Phys. 2022 Aug;49(8):5216-5224. doi: 10.1002/mp.15687. Epub 2022 May 17. Med Phys. 2022. PMID: 35533237 Free PMC article.

6

Prostate and dominant intraprostatic lesion segmentation on PET/CT using cascaded regional-net.

Matkovic LA, Wang T, Lei Y, Akin-Akintayo OO, Abiodun Ojo OA, Akintayo AA, Roper J, Bradley JD, Liu T, Schuster DM, Yang X. Matkovic LA, et al. Among authors: akin akintayo oo. Phys Med Biol. 2021 Dec 7;66(24):10.1088/1361-6560/ac3c13. doi: 10.1088/1361-6560/ac3c13. Phys Med Biol. 2021. PMID: 34808603 Free PMC article.

7

Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on ¹⁸F-Fluciclovine PET/CT Guidance.

Abiodun-Ojo OA, Jani AB, Akintayo AA, Akin-Akintayo OO, Odewole OA, Tade FI, Joshi SS, Master VA, Fielder B, Halkar RK, Zhang C, Goyal S, Goodman MM, Schuster DM. Abiodun-Ojo OA, et al. Among authors: akin akintayo oo. J Nucl Med. 2021 Aug 1;62(8):1089-1096. doi: 10.2967/jnumed.120.256784. Epub 2021 Jan 30. J Nucl Med. 2021. PMID: 33517323 Free PMC article.

8

¹⁸F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer.

Abiodun-Ojo OA, Akintayo AA, Akin-Akintayo OO, Tade FI, Nieh PT, Master VA, Alemozaffar M, Osunkoya AO, Goodman MM, Fei B, Schuster DM. Abiodun-Ojo OA, et al. Among authors: akin akintayo oo. J Nucl Med. 2019 Nov;60(11):1531-1536. doi: 10.2967/jnumed.119.227033. Epub 2019 Apr 6. J Nucl Med. 2019. PMID: 30954940 Free PMC article. Clinical Trial.

9

Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer.

Fei B, Abiodun-Ojo OA, Akintayo AA, Akin-Akintayo O, Tade F, Nieh PT, Master VA, Alemozaffar M, Osunkoya AO, Goodman MM, Schuster DM. Fei B, et al. J Urol. 2019 Aug;202(2):413-421. doi: 10.1097/JU.0000000000000200. Epub 2019 Jul 8. J Urol. 2019. PMID: 30817240 Free PMC article. Clinical Trial.

10

Uptake of 18F-Fluciclovine in Paget Disease.

Akin-Akintayo OO, Bonta D, Barron B. Akin-Akintayo OO, et al. Clin Nucl Med. 2019 Nov;44(11):e614-e616. doi: 10.1097/RLU.0000000000002670. Clin Nucl Med. 2019. PMID: 31283597

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page